5,6-二甲氧基-2-（4-吡啶甲基）-1-茚酮/多萘哌齐杂质B

5,6-Dimethoxy-2-(4-pyridylmethyl)-1-indanone

分析标准品,≥90%

5-(3-二甲氨基丙基)-10,11-二氢二苯并[A,D]环庚烯-5-醇

5-(3-DIMETHYLAMINOPROPYL)-10,11-DIHYDRO-5H-DIBENZO[A,D]CYCLOHEPTEN-5-OL

分析标准品,≥90%

N-[（2E）-6,6-二甲基-2-庚烯-4-炔-1-基]-N，4-二甲基-1-萘甲胺盐酸盐(盐酸特比奈芬杂质D)

N-[(2E)-6,6-Dimethyl-2-hepten-4-yn-1-yl]-N,4-dimethyl-1-naphthalenemethanamine Hydrochloride

分析标准品,≥90%

（R）-α - 〔（2,2-二甲基-1-氧代丙基）氨基] -4-羟基苯乙酸

(R)-α-[(2,2-Dimethyl-1-oxopropyl)amino]-4-hydroxybenzeneacetic Acid

分析标准品,≥90%

Dihydroxy Oxaliplatin-Pt(IV)

Dihydroxy Oxaliplatin-Pt(IV)

分析标准品,≥90%

粉色E

PEAK E

分析标准品,≥90%

5-Ethyl-3-[[(2R)-1-methyl-2-pyrrolidinyl]methyl]-1H-indole

5-Ethyl-3-[[(2R)-1-methyl-2-pyrrolidinyl]methyl]-1H-indole

分析标准品,≥90%

（E / Z）-FK-50626,28-烯丙基酯重排杂质

(E/Z)-FK-506 26,28-Allylic Ester Rearrangement Impurity

分析标准品,≥90%

N-1-Ethyl-1-demethylethyl Torsemide

N-1-Ethyl-1-demethylethyl Torsemide

分析标准品,≥90%

(4S)-3-[(2R,5S)-5-(4-氟苯基)-2-[(S)-[(4-氟苯基)氨基](4-羟基苯基)甲基]-5-羟基-1-氧代戊基]-4-苯基-2-恶唑烷酮

(S)-3-((2R,5S)-5-(4-fluorophenyl)-2-((S)-(4-fluorophenylaMino)(4-hydroxyphenyl)Methyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one

分析标准品,≥90%

奥利司他杂质

(2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic Acid (Orlistat Impurity)

分析标准品,≥90%

4-Epi Minocycline (>80%, contains unidentified salts)

4-Epi Minocycline (>80%, contains unidentified salts)

分析标准品,≥90%

6β-Hydroxy Norgestrel

6β-Hydroxy Norgestrel

分析标准品,≥90%

6α-Hydroxy Ethynyl Estradiol

6α-Hydroxy Ethynyl Estradiol

分析标准品,≥90%

Isopilocarpic Acid Sodium Salt

Isopilocarpic Acid Sodium Salt

分析标准品,≥90%

6β-Hydroxy Norethindrone

6β-Hydroxy Norethindrone

分析标准品,≥90%

6-Keto Ethynyl Estradiol

6-Keto Ethynyl Estradiol

分析标准品,≥90%

(1s)-5-苯基-2,3-二氢-1H-吡啶-1-羧酸

(S)-Ketorolac

分析标准品,≥90%

6β-Naltrexol (1.0 mg/mL in Methanol)

6β-Naltrexol (1.0 mg/mL in Methanol)

分析标准品,≥90%

12-O-Methyl Clarithromycin

12-O-Methyl Clarithromycin

分析标准品,≥90%